Nothing Special   »   [go: up one dir, main page]

Li et al., 2013 - Google Patents

MicroRNA in human glioma

Li et al., 2013

View HTML
Document ID
1737956878450352951
Author
Li M
Li J
Liu L
Li W
Yang Y
Yuan J
Publication year
Publication venue
Cancers

External Links

Snippet

Glioma represents a serious health problem worldwide. Despite advances in surgery, radiotherapy, chemotherapy, and targeting therapy, the disease remains one of the most lethal malignancies in humans, and new approaches to improvement of the efficacy of anti …
Continue reading at www.mdpi.com (HTML) (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/14—Type of nucleic acid interfering N.A.
    • C12N2310/141—MicroRNAs, miRNAs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A61K31/713—Double-stranded nucleic acids or oligonucleotides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Hybridisation probes
    • C12Q1/6883—Hybridisation probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2320/00—Applications; Uses
    • C12N2320/30—Special therapeutic applications
    • C12N2320/31—Combination therapy

Similar Documents

Publication Publication Date Title
Li et al. MicroRNA in human glioma
Rawat et al. MicroRNA in pancreatic cancer: from biology to therapeutic potential
Mansoori et al. HMGA2 as a critical regulator in cancer development
Ji et al. Targeting microRNAs in cancer gene therapy
Ding et al. MicroRNAs involved in carcinogenesis, prognosis, therapeutic resistance, and applications in human triple-negative breast cancer
Buruiană et al. The roles of miRNA in glioblastoma tumor cell communication: diplomatic and aggressive negotiations
Irimie et al. Current insights into oral cancer epigenetics
Makowska et al. microRNAs (miRNAs) in glioblastoma multiforme (GBM)—recent literature review
Ginn et al. LncRNAs in non-small-cell lung cancer
Palmini et al. What is new in the miRNA world regarding osteosarcoma and chondrosarcoma?
Godlewski et al. MicroRNA in brain pathology: Neurodegeneration the other side of the brain cancer
Lopez-Camarillo et al. MetastamiRs: non-coding microRNAs driving cancer invasion and metastasis
Anwar et al. MicroRNAs: emerging novel clinical biomarkers for hepatocellular carcinomas
Cellini et al. Role of microRNA in response to ionizing radiations: evidences and potential impact on clinical practice for radiotherapy
Wong et al. Exosomal MicroRNAs and organotropism in breast cancer metastasis
Chauhan et al. miR-205: a potential biomedicine for cancer therapy
Hilmarsdottir et al. Functional role of the microRNA-200 family in breast morphogenesis and neoplasia
Latowska et al. Non-coding RNAs in brain tumors, the contribution of lncRNAs, circRNAs, and snoRNAs to cancer development—their diagnostic and therapeutic potential
Sati et al. MicroRNAs regulate cell cycle and cell death pathways in glioblastoma
Ahmed et al. Glioblastoma and miRNAs
Kirstein et al. The role of miRNA for the treatment of MGMT unmethylated glioblastoma multiforme
Feng et al. The role of MicroRNA in the regulation of tumor epithelial–mesenchymal transition
Arrighetti et al. miRNAs as therapeutic tools and biomarkers for prostate cancer
Diab et al. The role of microRNAs in the diagnosis and treatment of pancreatic adenocarcinoma
Hassanein et al. Cell behavior of non-small cell lung cancer is at EGFR and microRNAs hands